Skip to main content

Advertisement

Table 1 Malaria vaccine projects funded by the EC FP5

From: Comparative decline in funding of European Commission malaria vaccine projects: what next for the European scientists working in this field?

Project Project Coordinator Partner EC Contribution Duration Start
Acronym Type Name/Institution Numbers Euros Months Date
EUROMALVAC1 RS D. Arnot, University of Edinburgh, UK 10 3 500 000 36 01-02-2000
ATTMAL RS A. Waters, Leiden University, NL 5 1 492 640 36 01-03-2000
MALTRANS RS R. Sauerwein, Radboud University Nijmegen Medical Centre, NL 11 2 499 962 36 01-03-2000
AMVTNETHIC AM S. Jepsen, Statens Serum Institut, DK 1 220 000 36 01-04-2000
PAMVAC RS M. Klinkert, Bernhard-Nocht-Institute for Tropical Medicine, DE 6 1 503 210 36 01-09-2001
NEMLAR AM S. Jepsen, Statens Serum Institut, DK 1 70 000 36 01-12-2001
EMLI DM P. Druilhe, Institut Pateur, FR 7 1 462 733 36 01-01-2002
EMVI AM S. Jepsen, Statens Serum Institut, DK 2 700 000 36 01-08-2002
EUROMALVAC2 RS D. Arnot, University of Edinburgh, UK 12 3 700 044 36 01-09-2002
VIRIMAL RS P. Preiser, Medical Research Council, UK 5 1 196 180 36 01-09-2002
AMVTN/AMANET CA S. Jepsen, Statens Serum Institut, DK 16 1 000 000 36 01-11-2002
Total EC contribution under FP5   17 344 769   
  1. AM: Accompanying Measures, CA: Coordination Action, DM: Demonstration, RS: Research